6-Bnz-cAMP sodium salt structure
|
Common Name | 6-Bnz-cAMP sodium salt | ||
|---|---|---|---|---|
| CAS Number | 1135306-29-4 | Molecular Weight | 455.294 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H15N5NaO7P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 6-Bnz-cAMP sodium salt6-Bnz-cAMP sodium salt is a cell-permeable cAMP analog. 6-Bnz-cAMP selectively activates cAMP-dependent PKA but not Epac signaling pathways[1]. |
| Name | 6-Bnz-cAMP sodium salt |
|---|---|
| Synonym | More Synonyms |
| Description | 6-Bnz-cAMP sodium salt is a cell-permeable cAMP analog. 6-Bnz-cAMP selectively activates cAMP-dependent PKA but not Epac signaling pathways[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C17H15N5NaO7P |
|---|---|
| Molecular Weight | 455.294 |
| Exact Mass | 455.060669 |
| 6-Bnz-cAMP |
| N6-benzoyl-Cyclic AMP (sodium salt) |
| 6-Bnz-cAMP sodium salt |
| MFCD01074967 |
| Sodium (4aR,6R,7R,7aS)-6-[6-(benzoylamino)-9H-purin-9-yl]-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide |
| N6-Benzoyladenosine-3',5'-cyclic monophosphate sodium salt |
| Benzamide, N-[9-[(4aR,6R,7R,7aS)-tetrahydro-2,7-dihydroxy-2-oxido-4H-furo[3,2-d]-1,3,2-dioxaphosphorin-6-yl]-9H-purin-6-yl]-, sodium salt (1:1) |